SWTX
SpringWorks Therapeutics
SWTX
SWTX
Delisted
SWTX was delisted on the 30th of June, 2025.
136 hedge funds and large institutions have $2.79B invested in SpringWorks Therapeutics in 2022 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 52 increasing their positions, 46 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
1% less capital invested
Capital invested by funds: $2.82B → $2.79B (-$24.9M)
5% less funds holding
Funds holding: 143 → 136 (-7)
33% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 21
Holders
136
Holding in Top 10
7
Calls
$33.6M
Puts
$29.9M
Top Buyers
| 1 | +$119M | |
| 2 | +$73.3M | |
| 3 | +$21.1M | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
+$18.4M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$16.8M |
Top Sellers
| 1 | -$18.2M | |
| 2 | -$12.1M | |
| 3 | -$11.4M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$9.76M |
| 5 |
Two Sigma Investments
New York
|
-$4.85M |